Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20032510HPVENSG00000186868.18protein_codingMAPTNoNo4137P10636
TVIS20020548HPVENSG00000186868.18protein_codingMAPTNoNo4137P10636
TVIS20020549HPVENSG00000186868.18protein_codingMAPTNoNo4137P10636
TVIS20020550HPVENSG00000186868.18protein_codingMAPTNoNo4137P10636
TVIS20020551HPVENSG00000186868.18protein_codingMAPTNoNo4137P10636
TVIS20020552HPVENSG00000186868.18protein_codingMAPTNoNo4137P10636
TVIS20020553HPVENSG00000186868.18protein_codingMAPTNoNo4137P10636
TVIS44029619HTLV-1ENSG00000186868.18protein_codingMAPTNoNo4137P10636
TVIS44012031HTLV-1ENSG00000186868.18protein_codingMAPTNoNo4137P10636
TVIS44047698HTLV-1ENSG00000186868.18protein_codingMAPTNoNo4137P10636
TCGA Plot Options
Drug Information
GeneMAPT
DrugBank IDDB00448
Drug NameLansoprazole
Target IDBE0003474
UniProt IDP10636
Regulation Type
PubMed IDs20110603
CitationsRojo LE, Alzate-Morales J, Saavedra IN, Davies P, Maccioni RB: Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's disease. J Alzheimers Dis. 2010;19(2):573-89. doi: 10.3233/JAD-2010-1262.
GroupsApproved; Investigational
Direct ClassificationSulfinylbenzimidazoles
SMILESCC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1
PathwaysLansoprazole Metabolism Pathway; Lansoprazole Action Pathway
PharmGKBPA450180
ChEMBLCHEMBL480